Ignite Creation Date:
2024-05-05 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00209014
Status:
TERMINATED
Last Update Posted:
2009-05-07
First Post:
2005-09-13
Brief Title:
Phase II Trial of Thalidomide in RefractoryRelapsed Diffuse Large B-Cell Lymphoma and Hodgkins Disease
Sponsor:
Emory University
Organization:
Emory University
Organization Data
Organization:
Emory University
Class:
OTHER
Study ID:
0544-2003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Emory University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Leonard Heffner MD
Old Organization:
Emory University Winship Cancer Institute
Collaborators
| Name | Class |
|---|---|
| Celgene Corporation | INDUSTRY |